![Nimish Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nimish Shah
Fondatore presso
APOGEE THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/07/2026
Profilo
Nimish P.
Shah is the founder of Apogee Therapeutics, Inc., founded in 2022, serving as Independent Director since 2023.
Current job includes Principal at Venrock Associates since 2013.
Former jobs include Director at Instil Bio, Inc. from 2020 to 2021, Research Analyst at Credit Suisse Securities (USA) LLC (Broker) from 2007 to 2010, Senior Consultant at Syneos Health Consulting, Inc. from 2006 to 2007, Associate at Novartis Pharmaceuticals Corp.
from 2002 to 2003, and Research Analyst at Surveyor Capital Ltd. from 2010 to 2013.
Education includes undergraduate degree from Rutgers State University of New Jersey in 2001, MBA from Columbia Business School, and graduate degree from Mailman School of Public Health.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/07/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Posizioni attive di Nimish Shah
| Società | Posizione | Inizio |
|---|---|---|
| APOGEE THERAPEUTICS, INC. | Fondatore | 01/01/2022 |
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Investitore di Private Equity | 01/07/2013 |
Precedenti posizioni note di Nimish Shah
| Società | Posizione | Fine |
|---|---|---|
| INSTIL BIO, INC. | Direttore/Membro del Consiglio | 17/12/2021 |
Surveyor Capital Ltd.
 Surveyor Capital Ltd. Investment Trusts/Mutual FundsMiscellaneous Surveyor Capital is a global, multi-manager equities strategy and is one of Citadel’s three fundamental equities businesses. Their sector-aligned investment teams conduct deep fundamental research, developing an independent view on the companies they cover. They are specialists in their industries and experts in their coverage, building trusted relationships with many corporate management teams. The firm's investment teams leverage Citadel’s proprietary, market-neutral risk framework with the aim of building portfolios that minimize broad market exposures. Using this insight, they act on their investment theses and scale their risk-taking with confidence. | Analyst-Equity | 01/06/2013 |
Credit Suisse Securities (USA) LLC (Broker)
 Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Syneos Health Consulting, Inc.
 Syneos Health Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides consulting services to pharmaceutical and biotech industries | Corporate Officer/Principal | - |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | - |
Formazione di Nimish Shah
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
95
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Credit Suisse Securities (USA) LLC (Broker)
Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Venrock Associates
Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Finance |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syneos Health Consulting, Inc.
Syneos Health Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides consulting services to pharmaceutical and biotech industries | Commercial Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Surveyor Capital Ltd.
Surveyor Capital Ltd. Investment Trusts/Mutual FundsMiscellaneous Surveyor Capital is a global, multi-manager equities strategy and is one of Citadel’s three fundamental equities businesses. Their sector-aligned investment teams conduct deep fundamental research, developing an independent view on the companies they cover. They are specialists in their industries and experts in their coverage, building trusted relationships with many corporate management teams. The firm's investment teams leverage Citadel’s proprietary, market-neutral risk framework with the aim of building portfolios that minimize broad market exposures. Using this insight, they act on their investment theses and scale their risk-taking with confidence. | Miscellaneous |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mailman School of Public Health
 Mailman School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Instil Bio, Inc.
 Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
Apogee Therapeutics, Inc.
 Apogee Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops therapies for immunological and inflammatory disorders | Health Technology |
